GeoVax Labs
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About GeoVax Labs
Geovax Labs Inc 是一家臨牀階段的生物技術公司，利用新型專有平臺開發針對傳染病和實體瘤癌症的人類疫苗和免疫療法。 GeoVax 的產品線包括正在進行的下一代 COVID-19疫苗的人體臨牀試驗和針對頭頸癌的基因導向療法。 其他研發項目包括針對猴痘 (MPox)、出血熱病毒（扎伊爾埃博拉、蘇丹埃博拉、馬爾堡和拉沙病毒）和寨卡病毒的預防性疫苗，以及針對多種實體瘤的免疫療法。
如何購買 GeoVax Labs (GOVX)
登入
1分鐘開戶
僅需1分鐘即可完成帳戶申請和驗證。整個過程完全自助，支援 RockFlow App 和網頁端操作。
充值資金
帳戶驗證完成後，您可以使用首選的支付方式向帳戶充值。
購買 GOVX
透過 RockFlow App 或網頁端搜尋 GOVX，輸入您想要投資的金額，然後點擊確認即可完成交易。
© Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.